malondialdehyde has been researched along with clostridium perfringens delta-toxin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, N; Liu, D; Liu, X; Luo, Y; Miao, Y; Wan, Q; Wang, Y; Zhong, J; Zhou, H | 1 |
1 other study(ies) available for malondialdehyde and clostridium perfringens delta-toxin
| Article | Year |
|---|---|
miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway.
Topics: Animals; Antioxidants; Carboxylic Ester Hydrolases; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Heme Oxygenase-1; Humans; Malondialdehyde; MicroRNAs; NF-E2-Related Factor 2; Oxidative Stress; Rats; Signal Transduction; Sulfhydryl Compounds; Thiones | 2017 |